A Randomized, Double‐blind, Placebo‐controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients
Quanzhong Liu(Tianjin Medical University General Hospital), Dongsheng Fan(King University), Hong Fang(Arkansas State University), Liyan Xi(Sun Yat-sen University), Haibo Chen(Peking University Shenzhen Hospital), Yi Fu(Shanghai Jiao Tong University), Ping Yan(Jiangsu Hengrui Medicine (China)), Zhen Hong(Fudan University), Li He(Sichuan University), Ningxiu Shang(Pfizer (China))
Cited by 31
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|951
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554